RxDoctor Payments Data

Ricardo Duran, MD

Undersea and Hyperbaric Medicine · Roswell, GANPI 1952591125

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations.

$2,117in general payments, 2019–2025

Across 91 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$354
  • Smith+Nephew$283
  • Organogenesis Inc.$238
  • Hydrofera LLC$167
  • AbbVie$165
  • Urgo Medical North America, LLC$129
  • plus $781 from 17 others

What the payments were for

  • Food & beverage$2,117100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few undersea and hyperbaric medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$166,546
Medicare patients
266
Services billed
1,525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate58$1,653
Pentoxifylline32$1,093
Doxycycline Monohydrate93$857
Betamethasone Dipropionate19$595
Mupirocin59$434
Clindamycin Hcl26$335
Ciprofloxacin Hcl37$204
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$146
Mometasone Furoate12$131
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$99

Paid to pharmacies, not to this prescriber.

Other undersea and hyperbaric medicine in Roswell

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →